Syndax Pharmaceuticals (SNDX)
(Delayed Data from NSDQ)
$15.45 USD
+0.70 (4.75%)
Updated Sep 18, 2025 04:00 PM ET
2-Buy of 5 2
F Value F Growth B Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
SNDX 15.45 +0.70(4.75%)
Will SNDX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for SNDX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SNDX
Wall Street Analysts Believe Syndax (SNDX) Could Rally 112.8%: Here's is How to Trade
Agilent Q3 Earnings Beat Estimates, Revenues Up Y/Y, Shares Rise
SNDX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Does Syndax (SNDX) Have the Potential to Rally 158.36% as Wall Street Analysts Expect?
Syndax Pharmaceuticals (SNDX) Reports Q2 Loss, Beats Revenue Estimates
All You Need to Know About Syndax (SNDX) Rating Upgrade to Buy
Other News for SNDX
SNDX: Revumenib Gains Key NCCN Recommendation for AML Treatment
Syndax announces updated NCCN Guidelines for AML
Syndax announces updated NCCN Guidelines for AML
SNDX forms Bollinger Band Squeeze on September 17
Is SNDX heading for a slide? Stochastic Reached Oversold shows up after crashing 5.05%